Pharma-Bio Serv (PBSV) Director Howard Spindel Transfers 42,504 Shares

What Happened
Howard Spindel, a director of Pharma‑Bio Serv, reported an other disposition (code J) on 2026-06-09 in which 42,504 shares were transferred with $0 proceeds (no sale). The Form 4 lists the transaction value as $0. The filing indicates the shares were transferred to the reporting person’s adult children following the death of the reporting person’s spouse.

Key Details

• Transaction date: 2026-06-09; reported on Form 4 filed 2026-07-22 (filed ~43 days after the transaction).
• Transaction type/code: Other acquisition/disposition (J) — listed as a disposition at $0.
• Shares involved: 42,504 shares; total proceeds reported: $0.
• Shares owned after transaction: not specified in the filing.
• Footnote: Transfer occurred following spouse’s death; Spindel disclaims beneficial ownership of these shares and states the report should not be taken as an admission of beneficial ownership for Section 16 or other purposes.
• Timeliness: The Form 4 was filed well after the usual two-business-day window; this reduces the timeliness of disclosure.

Context
This was a transfer/assignment (not an open‑market sale or purchase) and appears to be a family transfer following a personal event. Transfers like this (gifts or estate-related moves) do not necessarily reflect the insider’s view of the company’s prospects. The filing’s disclaimer means Spindel does not claim ongoing beneficial ownership of the transferred shares.